NRXPW vs SYF · rev $242.0K vs rev $11.19B
NRx Pharmaceuticals Inc (NRXPW) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
SYF (SYF) common stock.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
NRXPW currently screens at market cap $714.6M. SYF currently screens at market cap $0.
Not investment advice. Open the NRXPW and SYF stock pages for the full models.
Not investment advice.